PRODUCT DESICCANT ISSUE

PRODUCT DESICCANT ISSUE was reported 34 times

PRODUCT DESICCANT ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 1 0.0055
1 DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE 1 0.0032
2 METHYLNALTREXONE BROMIDE 1 0.0007
3 FEZOLINETANT 1 0.0004
4 PRUCALOPRIDE 1 0.0004
5 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 2 0.0003
6 LINACLOTIDE 5 0.0002
7 NORETHINDRONE 1 0.0002
8 PANCRELIPASE 6 0.0002
9 ALECTINIB HYDROCHLORIDE 1 0.0001
10 DUTASTERIDE 1 0.0001
11 BUPROPION HYDROCHLORIDE 5 0.0001
12 INSULIN DEGLUDEC 1 0.0000
13 OLMESARTAN MEDOXOMIL 1 0.0000
14 UPADACITINIB 2 0.0000
15 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 2 0.0000
16 DAPAGLIFLOZIN 1 0.0000
17 INSULIN ASPART 1 0.0000
18 METOPROLOL SUCCINATE ER TABLETS 1 0.0000
19 ROSUVASTATIN 1 0.0000
20 METOPROLOL SUCCINATE 1 0.0000
21 CLOPIDOGREL BISULFATE 1 0.0000
22 SACUBITRIL AND VALSARTAN 1 0.0000
23 FAMOTIDINE 1 0.0000
24 ZOLPIDEM TARTRATE 1 0.0000
25 TIRZEPATIDE 1 0.0000
26 CLOPIDOGREL 1 0.0000
27 FOLIC ACID 1 0.0000
28 PANTOPRAZOLE 1 0.0000
29 ALBUTEROL SULFATE 1 0.0000
30 METHOTREXATE SODIUM 1 0.0000